Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the third quarter ended September 30, ...

The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, ...

Autolus Therapeutics ( (AUTL) ) has provided an announcement. Autolus Therapeutics has achieved a pivotal milestone with the FDA’s ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired Elanco Animal ...

Autolus Therapeutics ( (AUTL)) has provided an update. Autolus Therapeutics plc has achieved FDA approval for AUCATZYL®, a treatment for relapsed and refractory B-cell acute lymphoblastic leukemia, ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Merus expects the FDA to make a decision on the application in February after reviewing additional manufacturing information it submitted.